Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
77 participants
OBSERVATIONAL
2025-06-20
2025-10-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Cross-sectional Study of Sarcopenia in Patients With Parkinson ' s Disease
NCT04721028
Exploring Sarcopenia in Parkinson's Disease Patients by Combining Serum Biomarker Levels
NCT06511531
Investigation of Exercise Capacity, Muscle Oxygenation and Physical Activity Level in Parkinson's Patients
NCT05816889
Non-motor Symptoms, Balance, Muscle Strength, and Functional Mobility in Patients With Parkinson's Disease
NCT04420910
Dual Task Training in Parkinson's Disease
NCT04115683
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study Group
Patients with Parkinson's Disease
No interventions assigned to this group
Control Group
Healthy individuals with similar demographic characteristics
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be diagnosed with Parkinson's Disease by a neurologist
* Stage 1-3 on the Modified Hoehn and Yahr Scale
Exclusion Criteria
* Elderly people with severe visual impairment, neurological disorders in addition to Parkinson's and/or congestive heart failure
* Older adults in whom exercise is not recommended
40 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Büşra Seçkinoğulları Korkusuz
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Süleyman Korkusuz, PhD
Role: STUDY_CHAIR
Atılım University
Ayla Fil Balkan, Assoc Prof
Role: STUDY_CHAIR
Hacettepe University
Gül Yalçın Çakmaklı, Assoc Prof
Role: STUDY_CHAIR
Hacettepe University
Büşra Seçkinoğulları Korkusuz, PhD
Role: PRINCIPAL_INVESTIGATOR
Ankara University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Atılım University
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, Ferrucci L, Guralnik JM, Fragala MS, Kenny AM, Kiel DP, Kritchevsky SB, Shardell MD, Dam TT, Vassileva MT. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014 May;69(5):547-58. doi: 10.1093/gerona/glu010.
Kara M, Kaymak B, Frontera W, Ata AM, Ricci V, Ekiz T, Chang KV, Han DS, Michail X, Quittan M, Lim JY, Bean JF, Franchignoni F, Ozcakar L. Diagnosing sarcopenia: Functional perspectives and a new algorithm from the ISarcoPRM. J Rehabil Med. 2021 Jun 21;53(6):jrm00209. doi: 10.2340/16501977-2851.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E-59394181-604.01-112205
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.